Apr 29 |
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
|
Apr 4 |
CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)
|
Apr 4 |
Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
|
Mar 11 |
We're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn
|
Mar 6 |
Soleno Therapeutics GAAP EPS of -$0.33 misses by $0.07
|
Mar 6 |
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
|
Feb 22 |
Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
|
Feb 14 |
Soleno Therapeutics, Inc. (SLNO) Is a Great Choice for 'Trend' Investors, Here's Why
|
Feb 5 |
Charter downgraded, Cigna upgraded: Wall Street's top analyst calls
|
Feb 1 |
Soleno Therapeutics to Present at Upcoming February Investor Conferences
|